Literature DB >> 3519270

Immunomodulating peptides.

G H Werner, F Floc'h, D Migliore-Samour, P Jollès.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3519270     DOI: 10.1007/bf01946691

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  53 in total

1.  Contribution to the study of the structure of adjuvant active waxes D from mycobacteria: Isolation of a peptidoglycan.

Authors:  D Migliore; P Jolles
Journal:  FEBS Lett       Date:  1968-11       Impact factor: 4.124

2.  Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide.

Authors:  W C Koff; S D Showalter; B Hampar; I J Fidler
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

3.  Regulatory role of a tripeptide (TKP) from the second constant domain of immunoglobulin G--I. Inhibition of rat and human macrophage activities.

Authors:  C Auriault; M Joseph; A Tartar; D Bout; A B Tonnel; A Capron
Journal:  Int J Immunopharmacol       Date:  1985

4.  Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.

Authors:  H Takeno; S Okada; K Hemmi; M Aratani; Y Kitaura; M Hashimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-08       Impact factor: 1.645

5.  Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms.

Authors:  H W McCain; I B Lamster; J M Bozzone; J T Grbic
Journal:  Life Sci       Date:  1982-10-11       Impact factor: 5.037

6.  Tuftsin stimulates thyrotropin secretion in rats.

Authors:  T Mitsuma; T Nogimori; M Chaya
Journal:  Experientia       Date:  1985-01-15

7.  Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides.

Authors:  E F Plow; D Freaney; T S Edgington
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

8.  A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar.

Authors:  D Migliore-Samour; J Bouchaudon; F Floc'h; A Zerial; L Ninet; G H Werner; P Jollès
Journal:  Life Sci       Date:  1980-03-17       Impact factor: 5.037

9.  Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.

Authors:  Y Mine; Y Yokota; Y Wakai; S Fukada; M Nishida; S Goto; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1983-08       Impact factor: 2.649

10.  Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts.

Authors:  D G Payan; D R Brewster; E J Goetzl
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  6 in total

Review 1.  Thymomodulin: biological properties and clinical applications.

Authors:  N M Kouttab; M Prada; P Cazzola
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 2.  Bioactive peptides and proteins from foods: indication for health effects.

Authors:  Niels Peter Möller; Katharina Elisabeth Scholz-Ahrens; Nils Roos; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2008-05-27       Impact factor: 5.614

3.  Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.

Authors:  G J Zigterman; H Snippe; M Jansze; E B Ernste; M J De Reuver; J M Willers
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

5.  Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease.

Authors:  L C Duffy; M A Zielezny; M Riepenhoff-Talty; T E Byers; J Marshall; M M Weiser; S Graham; P L Ogra
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

6.  Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy.

Authors:  K Zehra; R Pal; S Y Rizvi; W Haq; B Kundu; J C Katiyar; K B Mathur
Journal:  Experientia       Date:  1995-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.